Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Galantamine plus trimipramine for smoking cessation
2004-001174-25Phase 2Completed
- Sponsor
- MyNeuroCure
- Start
- Jul 2004
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in nicotine dependence comparing Galantamine plus trimipramine with Placebo (2 arms). Primary endpoint: Main Efficacy Criteria. Started Jul 2004; status: completed.
02
Drugs
trimipraminegalantamine
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on 2004-001174-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001174-25.